Related content

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite

The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats

By Jarbe T.U.C.   DiPatrizio N.V.   Li C.   Makriyannis A.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 4, 2003-07 ,pp. : 809-821

Elsevier

Access to resources Recommend Favorite

Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB 1 receptor antagonist, SR 141716

By Vacca G.   Serra S.   Brunetti G.   Carai M.A.M.   Gessa G.L.   Colombo G.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 55-59

Elsevier

Access to resources Recommend Favorite

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A

By Aceto M.D.   Scates S.M.   Lowe J.A.   Martin B.R.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats

By Serra S.   Carai M.A.M.   Brunetti G.   Gomez R.   Melis S.   Vacca G.   Colombo G.   Gessa G.L.  

European Journal of Pharmacology, Vol. 430, Iss. 2, 2001-11 ,pp. : 369-371

Elsevier

Access to resources Recommend Favorite